Prostate cancer

Prostate cancer

Genetic 'handbrake' could be key to stopping prostate cancer growth

EXCLUSIVE: A Nottingham team has received £271,000 from Prostate Cancer UK to investigate a promising new treatment avenue.

Researchers are exploring the potential of a genetic 'handbrake' that could play a crucial role in halting the growth of prostate cancer cells. This innovative approach has sparked optimism within the medical community, as it offers a new pathway for developing targeted therapies to combat this prevalent form of cancer.